West Pharmaceutical Services and Japan’s Daikyo Seiko team on container technology they claim will help drugmakers ensure consistency during scale-up operations
Sosei has revealed its intention to acquire Activus Pharma in a deal which allows the Japan-based firm to get their hands on Activus' nanoparticle drug formulation tools, a technology that’s in its infancy but holds great potential.
A deal to broaden Gilead’s research expertise into protein kinase biology has been finalised with the $120m acquisition of CGI Pharmaceuticals, in a deal that compliments its comprehensive selection of anti-HIV treatments.
Tanabe Research Labs (TRL) has revealed details of its new San Diego facility in which the revised layout of the site allows a fresh focus on antibody and biological approaches to autoimmune diseases such as diabetes and rheumatoid arthritis.
Regulus Therapeutics’ microRNA satellite technology has won the firm its biggest deal to date with French drugmaker Sanofi-Aventis agreeing a development accord worth up to $750m (€606m).
Aphios has been awarded a patent that details an improved process to formulate a polymer-based drug delivery nanotechnology platform. The method offers a more sustainable, consistent administration of therapeutics with less dosage-dependent side effects.
ViroPharma is seeking permission from the Food and Drug Administration (FDA) to increase production of Cinryze to an industrial scale as part of its ongoing expansion activities.
Researchers believe they have found a way of transforming a key element of liquid crystal display (LCD) televisions into a substance that can be used in pills and dressings designed to deliver drugs to certain parts of the body.
